Correction to "Discovery of Hydroxamic Acid Ester Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer"

J Med Chem. 2026 Mar 26;69(6):7491-7492. doi: 10.1021/acs.jmedchem.6c00616. Epub 2026 Mar 7.
No abstract available

Publication types

  • Published Erratum